Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
adverse effect observed

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

There is no data for CAS # 102242 -57 -9 available but for the single components which can be used for read across:

Acute toxicity oral

Benzene (ca. 50 % in the substance):

An oral LD50 value in rats of > 2000 mg/kg is derived from two studies (Kimura et al, 1971; Withey and Hall, 1975). Although little information on clinical signs is included in these publications the EU RAR (2008) stated "depending on the dose the main clinical signs are sedation and hind-limb paralysis".

Cyclopentene (and 1 -methylcyclopentene) (together ca. 17 % in the substance):

The oral LD50 for cyclopentene was 1656 mg/kg in male rats (Smyth H.F. et.al. 1962 and 1969). Based on structural similarities it can be assumed that the oral LD50 for 1 -methylcyclopentene will also be in the range of 300 to 2000 mg/kg.

Based on a weight of evidence approach the oral LD50 of the substance will be in the range of > 300 and < 2000 mg/kg.

Justification for classification or non-classification

Based on the available data an R22 according to DSD-DPD and the Acute oral Cat. 4 according to CLP is warranted.